H L Ramos1, G Valencia-Pacheco, J Alcocer-Varela. 1. Department of Immunology and Rheumatology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico. ramosh@mail.nih.gov
Abstract
OBJECTIVE: Signal transducers and activators of transcription (STATs) are crucial mediators of cytokine signalling. Constitutive activation of STATs, especially STAT3, has been reported in several diseases. Primary Sjögren's syndrome (pSS) is associated with overproduction of cytokines such as interleukin-10 (IL-10), although the mechanism by which this occurs is unknown. As STAT3 is a potent inducer of IL-10, this study focused on determining the pattern of STAT3 activation in peripheral lymphocytes from patients with pSS. METHODS: Twelve pSS patients and 12 healthy age-matched control subjects were studied. Peripheral blood mononuclear cells (PBMCs) were isolated by gradient centrifugation. Phosphorylated STAT3 (pSTAT3) and also STAT3 expression were determined by flow cytometry in gated CD3(+ )and CD19(+) lymphocytes. Similarly, pJak1 and pTyk2 were also determined in gated CD3(+) lymphocytes. RESULTS: Although the protein expression of STAT3 was similar among controls and pSS patients, we found that STAT3 was constitutively activated in CD3(+) lymphocytes from pSS patients. Neither Jak1 nor Tyk2 (the upstream activators of STAT3) was activated in pSS CD3(+) lymphocytes, suggesting that the constitutive activation of STAT3 observed in pSS patients might not depend on cytokine stimulation but instead might be the result of an abnormal inactivation of pSTAT3. CONCLUSIONS: These data provide evidence of abnormal STAT3 signalling in T cells from pSS patients.
OBJECTIVE: Signal transducers and activators of transcription (STATs) are crucial mediators of cytokine signalling. Constitutive activation of STATs, especially STAT3, has been reported in several diseases. Primary Sjögren's syndrome (pSS) is associated with overproduction of cytokines such as interleukin-10 (IL-10), although the mechanism by which this occurs is unknown. As STAT3 is a potent inducer of IL-10, this study focused on determining the pattern of STAT3 activation in peripheral lymphocytes from patients with pSS. METHODS: Twelve pSSpatients and 12 healthy age-matched control subjects were studied. Peripheral blood mononuclear cells (PBMCs) were isolated by gradient centrifugation. Phosphorylated STAT3 (pSTAT3) and also STAT3 expression were determined by flow cytometry in gated CD3(+ )and CD19(+) lymphocytes. Similarly, pJak1 and pTyk2 were also determined in gated CD3(+) lymphocytes. RESULTS: Although the protein expression of STAT3 was similar among controls and pSSpatients, we found that STAT3 was constitutively activated in CD3(+) lymphocytes from pSSpatients. Neither Jak1 nor Tyk2 (the upstream activators of STAT3) was activated in pSS CD3(+) lymphocytes, suggesting that the constitutive activation of STAT3 observed in pSSpatients might not depend on cytokine stimulation but instead might be the result of an abnormal inactivation of pSTAT3. CONCLUSIONS: These data provide evidence of abnormal STAT3 signalling in T cells from pSSpatients.
Authors: Hanna L M Koskela; Samuli Eldfors; Pekka Ellonen; Arjan J van Adrichem; Heikki Kuusanmäki; Emma I Andersson; Sonja Lagström; Michael J Clemente; Thomas Olson; Sari E Jalkanen; Muntasir Mamun Majumder; Henrikki Almusa; Henrik Edgren; Maija Lepistö; Pirkko Mattila; Kathryn Guinta; Pirjo Koistinen; Taru Kuittinen; Kati Penttinen; Alun Parsons; Jonathan Knowles; Janna Saarela; Krister Wennerberg; Olli Kallioniemi; Kimmo Porkka; Thomas P Loughran; Caroline A Heckman; Jaroslaw P Maciejewski; Satu Mustjoki Journal: N Engl J Med Date: 2012-05-17 Impact factor: 91.245
Authors: Jani Oiva; Harri Mustonen; Marja-Leena Kylänpää; Lea Kyhälä; Krista Kuuliala; Sanna Siitonen; Esko Kemppainen; Pauli Puolakkainen; Heikki Repo Journal: Crit Care Date: 2010-11-18 Impact factor: 9.097
Authors: Richard Davies; Irene Sarkar; Daniel Hammenfors; Brith Bergum; Petra Vogelsang; Silje M Solberg; Sonia Gavasso; Johan G Brun; Roland Jonsson; Silke Appel Journal: Front Immunol Date: 2019-02-21 Impact factor: 7.561
Authors: Irene Sarkar; Richard Davies; Anders K Aarebrot; Silje M Solberg; Aleksandra Petrovic; Anagha M Joshi; Brith Bergum; Johan G Brun; Daniel Hammenfors; Roland Jonsson; Silke Appel Journal: Front Immunol Date: 2022-08-22 Impact factor: 8.786
Authors: S R Vartoukian; W M Tilakaratne; N Seoudi; M Bombardieri; L Bergmeier; A R Tappuni; F Fortune Journal: Clin Exp Immunol Date: 2014-09 Impact factor: 4.330
Authors: Ariana Dela Cruz; Vinay Kartha; Andrew Tilston-Lunel; Rongjuan Mi; Taylor L Reynolds; Michael Mingueneau; Stefano Monti; Janicke L Jensen; Kathrine Skarstein; Xaralabos Varelas; Maria A Kukuruzinska Journal: Sci Rep Date: 2021-05-27 Impact factor: 4.379